Genentech reports positive clinical results in Avastin trial Report projects breast cancer drug sales to exceed $1 billion Centric Health Resources supports third annual Rare Disease Day FDA committee recommends approval of Xifaxan Inhaled CF antibiotic receives FDA approval Combined HIV drug therapy may cause heart rhythm issues Decision Resources projects Crohn's disease market surge FDA approves Parkinson's disease treatment FDA approved more than 50 cancer drugs in two years, study says Novartis' Tasigna receives priority review from FDA First Previous 209 210 211 212 213 Next Last